Testosterone therapy has gained widespread attention in recent years as men seek to improve energy levels, muscle mass, libido, and mood. As men age, testosterone levels naturally decline, sometimes leading to symptoms like fatigue, depression, reduced sexual performance, and decreased physical endurance. For many, testosterone replacement therapy (TRT) offers significant relief. However, concerns about its impact on prostate health have led to important questions about safety and long-term outcomes. At 1Prostate Center in Manhattan and Queens, Dr. David Shusterman guides patients through these complex issues with expert insight and personalized care.
The relationship between testosterone therapy and prostate health is nuanced. Historically, there was concern that testosterone therapy could increase the risk of prostate cancer or worsen symptoms of benign prostatic hyperplasia (BPH). Newer research offers a more refined understanding, showing that with proper screening and management by an experienced urology doctor in NYC, testosterone therapy can be both safe and beneficial for the right patients. As a leader in prostate cancer treatment in Midtown Manhattan, Dr. Shusterman ensures patients receive evidence-based care and ongoing monitoring when undergoing hormone therapy.
Understanding the Role of Testosterone in the Male Body
Testosterone is a vital hormone that influences a wide range of functions, from sexual health and bone density to red blood cell production and emotional well-being. A decline in testosterone—often referred to as andropause—can produce symptoms that significantly affect quality of life. At 1Prostate Center, patients seeking relief from these symptoms are carefully evaluated to determine if they are candidates for TRT.
While the benefits of testosterone therapy can be substantial, the hormone also plays a role in prostate growth and development. This has led to the theory that increasing testosterone levels could stimulate prostate cancer cells or worsen an enlarged prostate. However, recent studies have shown that men with normal testosterone levels are no more likely to develop prostate cancer than those with low levels. Moreover, when administered and monitored properly, TRT does not appear to increase the risk of developing aggressive prostate disease. Still, ongoing screening is essential, especially for those at higher risk or with a history of urinary incontinence, erectile dysfunction, or BPH symptoms.
Evaluating Prostate Health Before Starting TRT
Before beginning testosterone therapy, it’s critical to evaluate a man’s prostate health thoroughly. Dr. Shusterman conducts a complete assessment at his urology clinic in NYC, which includes a detailed medical history, PSA (prostate-specific antigen) testing, digital rectal examination (DRE), and possibly imaging studies if needed. These baseline tests help determine if any underlying prostate issues need to be addressed before hormone therapy begins.
Patients who already have symptoms of an enlarged prostate—such as weak urine stream, frequent urination, or urinary urgency—must be evaluated for BPH. For those seeking enlarged prostate treatment in Midtown Manhattan, Dr. Shusterman offers a range of options, from medications to minimally invasive surgical techniques. Managing these conditions before or alongside testosterone therapy ensures safer outcomes and improves the effectiveness of treatment. Men who are also dealing with kidney stones or urinary incontinence may benefit from a coordinated approach that addresses multiple issues at once, all under the expertise of a single urologist near Midtown Manhattan.
Monitoring and Managing Prostate Health During TRT
Testosterone therapy is not a set-it-and-forget-it treatment. Ongoing monitoring is essential to ensure safety and adjust therapy as needed. At 1Prostate Center, patients undergoing TRT are seen regularly for follow-up visits that include PSA testing, evaluation of urinary symptoms, and assessment of therapy effectiveness. If prostate changes are detected, prompt intervention can prevent progression and reduce the risk of complications.
One of the concerns with TRT is the potential exacerbation of BPH symptoms due to hormonal stimulation. This is why regular symptom tracking and periodic imaging may be recommended for patients with pre-existing enlarged prostates. If symptoms develop or worsen, treatments such as UroLift or laser therapy can be incorporated into the care plan without discontinuing hormone therapy. Dr. Shusterman’s expertise in prostate cancer treatment in Midtown Manhattan means that any signs of cancerous changes will be identified and treated promptly, using the latest diagnostic and therapeutic options.
Additionally, men concerned about sexual function often seek TRT to improve libido and performance. If erectile dysfunction is present, it may be a sign of vascular issues or hormonal imbalance. As part of a comprehensive treatment strategy, Dr. Shusterman evaluates all contributing factors and provides advanced erectile dysfunction treatment in Midtown Manhattan tailored to each patient’s needs.
Integrative Care for Hormone and Urologic Health
At 1Prostate Center, testosterone therapy is never offered in isolation. Dr. Shusterman provides integrative care that includes nutritional guidance, weight management, cardiovascular risk evaluation, and urologic screening. Because hormonal health is closely linked to urologic and metabolic health, this full-spectrum approach produces more sustainable results and fewer risks.
Patients benefit from a comprehensive evaluation that covers more than just testosterone levels. Whether you’re struggling with fatigue, low libido, or symptoms of BPH, addressing the root cause is essential for lasting relief. Dr. Shusterman frequently helps patients manage overlapping concerns—such as kidney stones treatment in Midtown Manhattan or urinary incontinence treatment—by combining expertise with a personalized touch. His reputation as the best urologist for prostate cancer in Midtown Manhattan speaks to his dedication to proactive care and long-term health outcomes.
For men seeking a “urologist near me in Midtown Manhattan” who can offer advanced TRT management, prostate care, and broader urologic treatment under one roof, 1Prostate Center delivers a level of care that is unmatched. By emphasizing safety, patient education, and continuous monitoring, Dr. Shusterman helps patients regain their vitality with confidence and peace of mind.
Making Informed Decisions About TRT and Prostate Health
Testosterone therapy can be life-changing for men struggling with hormonal decline—but it must be approached with caution and expertise. At 1Prostate Center, Dr. David Shusterman provides safe, science-backed TRT options with a deep understanding of the potential effects on prostate health. Whether you are dealing with the early symptoms of low testosterone or have been considering therapy for some time, you deserve clear answers and thorough care.
With locations in Manhattan and Queens, 1Prostate Center makes it easy to access expert urologic care tailored to your unique health goals. From prostate cancer treatment and enlarged prostate care to erectile dysfunction and kidney stones treatment, Dr. Shusterman delivers comprehensive support with a focus on long-term well-being. Don’t let myths or misinformation stop you from exploring your options—schedule a consultation today with a top urology doctor in NYC.
Resources
Morgentaler, A., et al. (2011). Testosterone Therapy and Prostate Cancer: An Historical Perspective on a Modern Myth. European Urology.
Baillargeon, J., et al. (2015). Risk of Prostate Cancer in Men Receiving Testosterone Therapy. Journal of Clinical Oncology.
Resnick, M. J., & Penson, D. F. (2013). Testosterone Replacement Therapy and Prostate Health. Current Urology Reports.
